Analysis

Cooley Attys Savor Amgen-Horizon Close After FTC Battle

By Al Barbarino · October 6, 2023, 7:36 PM EDT

Upon the close of Amgen's $28 billion acquisition of Ireland's Horizon Therapeutics on Friday, following a tense battle with the Federal Trade Commission, Cooley LLP partners representing Horizon said the end...

To view the full article, register now.